Antioxidant Activity of Telmisartan–Cu(II) Nanoparticles Connected 2-Pyrimidinamine and Their Evaluation of Cytotoxicity Activities

Figure 8

(a) AFM image of Cu-Np catalyst. (b) The profile of Cu in telmisartan-mediated copper nanaoparicles. (c) The waviness of Cu-Nps. (d) The roughness of Cu-Nps.

(a)

(b)

(c)

(d)